2Tabata M,Yoshida M,Izumi T,et al.Retrospective analysis of elderly patients》or = 60 years of age with acute leukemia[ J].Rinsho Ketsueki,1998; 39 (3):176-84.
3Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin, 1995, 45: 127-128.
4Kantarjian H, O'Brien S, Cones J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer, 2006, 106: 1090-1098.
5Tilly H, Castaigne S, Bordessoule D, et al. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol, 1990, 8: 272-279.
6Pulsoni A, Pagano L, Latagliata R, et al. Survival of elderly patients with acute myeloid leukemia. Haematologica, 2004, 89: 296-302.
7Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood, 2006, 107: 3481-3485.
8Kansal V, Omura GA, Soong SJ. Prognosis in adult acute myelogenous leukemia related to performance status and other factors. Cancer, 1976, 38: 329-334.
9DeLima M, Ghaddar H, Pierce S, et al. Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above. Br J Haematol, 1996, 93: 89-95.
10Ferrara F, Annunziata M, Copia C, et al. Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia. Haematologica, 1998, 83:126-131.
